Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion type Assertion NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_head.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion description "[We studied the responses of bcl-2 and bcl-X(L) genes in pharmacologic (acute incubation with methylpyridinium (MPP+)) and mitochondrial transgenic (`cybrid`) models of Parkinson disease C-I defects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_provenance.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion evidence source_evidence_literature NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_provenance.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion SIO_000772 10972966 NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_provenance.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion wasDerivedFrom befree-20140225 NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_provenance.
- NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_assertion wasGeneratedBy ECO_0000203 NP195753.RA4xtv1O_H_RVtqeubpJQgC8GxlEYjdQlAuLnXBk5o__Q130_provenance.